FDA Approves iDose TR (travoprost intracameral implant) for the Treatment of Glaucoma

ALISO VIEJO, Calif.--(BUSINESS WIRE) December 14, 2023 -- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news